Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeMedia CenterPress releases Medical technologiesDePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA® HP Partial Knee on the Navio™ Surgical System

      DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA® HP Partial Knee on the Navio™ Surgical System

      Share Article
      share to

      WARSAW, IN – (September 17, 2014) DePuy Synthes, the world’s largest provider of orthopaedic and neurological solutions, announced today a worldwide commercial agreement with Blue Belt Technologies, a global medical technology company specializing in enabling technologies for orthopaedic surgery.

      The agreement will enable orthopaedic surgeons to use the SIGMA® HP Partial Knee System with Blue Belt’s Navio™ surgical system. SIGMA HP, combined with Navio surgical system for orthopaedic surgery, has the potential to help minimize surgical disruption of healthy tissue while enabling more precise implant placement through minimally invasive incisions. The Navio System combines CT-free navigation software with a hand-held computer controlled bone shaping tool that is designed to bring a high degree of implant placement accuracy along with soft tissue balancing benefits.

      Today, approximately seven percent of all knee replacement patients worldwide are treated with uni-compartmental knees.1 The SIGMA HP Partial Knee is the only truly modular system specifically designed to allow uni-compartmental, bi-compartmental (unicompartmental tibiofemoral with patellofemoral) or staged replacement of the knee joint, meaning surgeons can match the implant specifically to a patient’s disease state to retain healthy bone, cartilage and ligaments.

      “Through this agreement, we’re now able to combine the benefits of the SIGMA HP Partial Knee, which enables surgeons to repair only the parts of the knee that are damaged, with Blue Belt’s proprietary technology that enables more precise implant placement and soft-tissue balancing to advance patient care, said Andrew Ekdahl, Company Group Chairman, DePuy Synthes Global Orthopaedic Franchise. “This is another example of how DePuy Synthes is advancing patient care while also making surgical processes and procedures more efficient for surgeons and the health care system overall.”

      DePuy Synthes
      DePuy Synthes Companies of Johnson & Johnson is the largest provider of orthopaedic and neurological solutions in the world. For more information, visit

      Important Safety Information
      The performance of knee replacements depends on a patient’s age, weight, activity level and other factors. There are potential risks and recovery takes time. People with conditions limiting rehabilitation should not have these surgeries. Only an orthopaedic surgeon can determine if knee replacement is necessary based on an individual patient’s condition.

      [1] Source: Global Data


      Mindy Tinsley
      DePuy Synthes Communication and Public Affairs

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.